Page 276

84. Schieber MH, Poliakov AV. 1998. Partial inactivation of the primary motor cortex hand area: effects on individuated finger movements. J Neurosci.; 18: 9038-54.

85. Shaw MK, Lorens JB, Dhawan A, et al. 1997. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med.; 185: 1711-4.

86. Smith-Jensen T, Burgoon MP, Anthony J, Kraus H, Gilden DH, Owens GP. 2000. Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology.; 54: 1227-32.

87. Sontheimer H, Waxman SG. 1992. Ion channels in spinal cord astrocytes in vitro. II. Biophysical and pharmacological analysis of two Na+ current types. J Neurophysiol.; 68: 1001-11.

88. Stein DG. Brain injury and theories of recovery. Goldstein LB, ed. Restorative Neurology: Advances in Pharmacotherapy for Recovery After Stroke. Armonk, NY: Futura Publishing Co., Inc.; 1998.

89. Steinman L. 2000. Multiple approaches to multiple sclerosis. Nat Med.; 6: 15-6.

90. Steinman RM, Turley S, Mellman I, Inaba K. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med.; 191: 411-6.

91. Stys PK, Sontheimer H, Ransom BR, Waxman SG. 1993. Noninactivating, tetrodotoxin-sensitive Na+ conductance in rat optic nerve axons. Proc Natl Acad Sci U S A.; 90: 6976-80.

92. Stys PK, Waxman SG, Ransom BR. 1992. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J Neurosci.; 12: 430-9.

93. Trapp BD, Peterson J, Ransohoff RM, Rudick RA, Mork S, Bo L. 1998. Axonal transection in the lesions of multiple sclerosis. New Engl J Med.; 338: 278-285.

94. Vandenbark AA, Hashim G, Offner H. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature.; 341: 541-4.

95. Waters RS, McCandlish CA. Organization and development of the forepaw representation in forepaw barrel subfield. Jones EG, Diamond IT, eds. Cerebral Cortex. New York: Plenum Press; 1995; 11.

96. Waubant E, Goodkin D. 2000. Methodological problems in evaluating efficacy of a treatment in multiple sclerosis. Pathol Biol (Paris).; 48: 104-13.

97. Waxman SG. 1978. Prerequisites for conduction in demyelinated fibers. Neurology.; 28: 27-33.

98. Waxman SG. 1982. Membranes, myelin, and the pathophysiology of multiple sclerosis. N Engl J Med.; 306: 1529-33.

99. Waxman SG. 1998. Demyelinating diseases—new pathological insights, new therapeutic targets. N Engl J Med.; 338: 323-5.

100. Wekerle H. 1992. Myelin specific, autoaggressive T cell clones in the normal immune repertoire: their nature and their regulation. Int Rev Immunol.; 9: 231-41.

101. Wekerle H, Linington C, Lassmann H, Meyermann R. 1986. Cellular immune reactivity within the CNS. Trends Neurosci.; 9: 271.

102. Werring DJ, Bullmore ET, Toosy AT, et al. 2000. Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study. J Neurol Neurosurg Psychiatry.; 68: 441-9.

103. Wilson DB, Pinilla C, Wilson DH, et al. 1999. Immunogenicity. I. Use of peptide libraries to identify epitopes that activate clonotypic CD4+ T cells and induce T cell responses to native peptide ligands. J Immunol.; 163: 6424-34.

104. Yarom Y, Naparstek Y, Lev-Ram V, Holoshitz J, Ben-Nun A, Cohen IR. 1983. Immunospecific inhibition of nerve conduction by T lymphocytes reactive to basic protein of myelin. Nature.; 303: 246-7.

105. Yeh TC, Zhang W, Ildstad ST, Ho C. 1995. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magn Reson Med.; 33: 200-8.

106. Zweiger G. 1999. Knowledge discovery in gene-expression-microarray data: mining the information output of the genome. Trends Biotechnol.; 17: 429-436.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement